Remicade and Lymphocytic infiltration - a phase IV clinical study of FDA data

Summary:

Lymphocytic infiltration is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Enbrel, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Lymphocytic infiltration when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Lymphocytic infiltration?

Lymphocytic infiltration (lymphocyte deposition) is found to be associated with 164 drugs and 346 conditions by eHealthMe. Check the latest studies of Lymphocytic infiltration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 12 people (0.01%) have Lymphocytic infiltration.

Could Remicade cause Lymphocytic infiltration?

Among these 12 people:

How long have people been on Remicade when they have Lymphocytic infiltration? *

What is the gender of people who have Lymphocytic infiltration when taking Remicade? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Lymphocytic infiltration when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Lymphocytic infiltration? *

Weight Decreased: 3 people, 25.00%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 16.67%
Splenomegaly (enlargement of spleen): 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 16.67%
Fatigue (feeling of tiredness): 1 person, 8.33%
Escherichia Infection (bacterial infection by escherichia coli): 1 person, 8.33%
Erythema Marginatum (pink rings on the trunk and inner surfaces of the limbs): 1 person, 8.33%
Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 1 person, 8.33%
Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 8.33%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 16.67%
Fistula (an abnormal connection or passageway between two): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Lymphocytic infiltration?

- Check whether Lymphocytic infiltration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphocytic infiltration:

Lymphocytic infiltration (164 drugs)

Browse all the conditions that are associated with Lymphocytic infiltration:

Lymphocytic infiltration (346 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.